Literature DB >> 24062238

Quality of life of glaucoma patients in China: sociodemographic, clinical, and psychological correlates-a cross-sectional study.

Chuandi Zhou1, Shaohong Qian, Peixia Wu, Chen Qiu.   

Abstract

PURPOSE: To assess vision-related quality of life (VRQoL) in Chinese glaucoma patients and explore its sociodemographic, clinical and psychological correlates, and determine which of them explain the largest variation.
METHODS: This cross-sectional study included 508 Chinese glaucoma patients. Chinese-version Glaucoma Quality of Life-15 questionnaire (CHI-GQL-15) and Hospital Anxiety and Depression Scales were administered to all participants to evaluate their VRQoL and psychological distresses. Visual functions (habitual-corrected visual acuity (HCVA), intraocular pressure, and mean defect (MD) of visual field) were assessed through clinical examinations by professionals. Sociodemographic information and other treatment histories were collected via interviews and chart review. Stepwise multiple linear regression analyses were performed to identify sociodemographic, clinical, and psychological predictors of VRQoL.
RESULTS: The mean summary score for CHI-GQL-15 was 28.79 ± 12.74. Patients exhibited the greatest difficulty in activities involving glare and dark adaptation (28.19 ± 22.86), followed by central and near vision (26.18 ± 26.56), peripheral vision (18.03 ± 21.37), and the least difficulty for outdoor mobility (15.06 ± 24.57). Moderate and heavy economic burden, HCVA and MD of both the better and the worse eyes, number of glaucoma surgeries in the treatment history and the presence of depression were independent predictors for VRQoL of glaucoma patients. Clinical factors explained the largest variation.
CONCLUSION: VRQoL of glaucoma patients is multifactorial and was primarily determined by clinical indices. VRQoL assessment could be informative when adopted as a complement to objective visual measures in clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 24062238     DOI: 10.1007/s11136-013-0518-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  32 in total

1.  The relationship between visual field loss in glaucoma and health-related quality-of-life.

Authors:  A van Gestel; C A B Webers; H J M Beckers; M C J M van Dongen; J L Severens; F Hendrikse; J S A G Schouten
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

2.  Increased antidepressant use in patients prescribed beta-blockers.

Authors:  J Avorn; D E Everitt; S Weiss
Journal:  JAMA       Date:  1986-01-17       Impact factor: 56.272

3.  Patients' perception of visual impairment in glaucoma: a pilot study.

Authors:  P Nelson; P Aspinall; C O'Brien
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

4.  Impact of severity and bilaterality of visual impairment on health-related quality of life.

Authors:  Rohit Varma; Joanne Wu; Kelly Chong; Stanley P Azen; Ron D Hays
Journal:  Ophthalmology       Date:  2006-08-04       Impact factor: 12.079

5.  Self-reported comorbidities and visual function in a population-based study: the Los Angeles Latino Eye Study.

Authors:  Denise R Globe; Rohit Varma; Mina Torres; Joanne Wu; Ronald Klein; Stanley P Azen
Journal:  Arch Ophthalmol       Date:  2005-06

Review 6.  An assessment of the health and economic burdens of glaucoma.

Authors:  Rohit Varma; Paul P Lee; Ivan Goldberg; Sameer Kotak
Journal:  Am J Ophthalmol       Date:  2011-10       Impact factor: 5.258

7.  Visual field staging systems in glaucoma and the activities of daily living.

Authors:  Kaushal M Kulkarni; Jason R Mayer; Luciano L Lorenzana; Jonathan S Myers; George L Spaeth
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

8.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

9.  Visual function, disability, and psychological impact of glaucoma.

Authors:  Undraa Altangerel; George L Spaeth; Douglas J Rhee
Journal:  Curr Opin Ophthalmol       Date:  2003-04       Impact factor: 3.761

10.  Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective.

Authors:  C M Leung; S Ho; C S Kan; C H Hung; C N Chen
Journal:  Int J Psychosom       Date:  1993
View more
  7 in total

1.  Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma.

Authors:  Y-S Kuo; C J-L Liu; H-C Cheng; M-J Chen; W-T Chen; Y-C Ko
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

2.  Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language.

Authors:  Ivan Sencanic; Tatjana Gazibara; Jelena Dotlic; Miroslav Stamenkovic; Vesna Jaksic; Marija Bozic; Anita Grgurevic
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

3.  Vision-related quality of life in patients with glaucoma: the role of illness perceptions.

Authors:  Qiqi Zhang; Wenzhe Zhou; Di Song; Yanqian Xie; Hao Lin; Youping Liang; Yanhan Ren; Yuanbo Liang; Yanyan Chen
Journal:  Health Qual Life Outcomes       Date:  2022-05-12       Impact factor: 3.077

Review 4.  Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma.

Authors:  Naomi Sj Ting; James Ft Li Yim; Jia Y Ng
Journal:  Clinicoecon Outcomes Res       Date:  2014-12-04

5.  Psychometric properties of the Glaucoma Quality of Life-15 questionnaire: Use of explanatory factor analysis.

Authors:  Hamideh Mahdaviazad; Narges Roustaei; Masoumeh Beigom Masoumpour; Mohammad Reza Razeghinejad
Journal:  J Curr Ophthalmol       Date:  2018-01-17

6.  Coping style and quality of life in elderly patients with vision disturbances.

Authors:  Maria Oles; Piotr Oles
Journal:  J Ophthalmol       Date:  2014-08-21       Impact factor: 1.909

7.  Objective Assessment of Activity Limitation in Glaucoma with Smartphone Virtual Reality Goggles: A Pilot Study.

Authors:  Rachel L Z Goh; Yu Xiang George Kong; Colm McAlinden; John Liu; Jonathan G Crowston; Simon E Skalicky
Journal:  Transl Vis Sci Technol       Date:  2018-01-23       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.